We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+3.2%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$112M
AUM Growth
+$2.51M
Cap. Flow
-$831K
Cap. Flow %
-0.74%
Top 10 Hldgs %
18.4%
Holding
164
New
24
Increased
48
Reduced
65
Closed
13

Top Buys

Rank Stock Value
1
DORM icon
Dorman Products
DORM
+$925K
2
FUL icon
H.B. Fuller
FUL
+$909K
3
WST icon
West Pharmaceutical
WST
+$805K
4
PG icon
Procter & Gamble
PG
+$778K
5
CAG icon
Conagra Brands
CAG
+$760K

Top Sells

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$1.15M
2
BAX icon
Baxter International
BAX
+$952K
3
NTRS icon
Northern Trust
NTRS
+$934K
4
TGT icon
Target
TGT
+$806K
5
SPXC icon
SPX Corp
SPXC
+$711K

Sector Composition

Rank Sector Weight
1 Industrials 23.8%
2 Healthcare 16.26%
3 Energy 13.01%
4 Financials 11.23%
5 Consumer Staples 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KMB icon
26
Kimberly-Clark
KMB
$37B
$1.15M 1.03%
10,791
-119
-1% -$12.6K
JCI icon
27
Johnson Controls International
JCI
$93.9B
$1.12M 1%
21,344
+2,530
+13% +$126K
AGCO icon
28
AGCO
AGCO
$7.31B
$1.09M 0.97%
19,350
+4,825
+33% +$266K
PFE icon
29
Pfizer
PFE
$145B
$1.07M 0.96%
38,192
-10
-0% -$285
PG icon
30
Procter & Gamble
PG
$340B
$1.05M 0.94%
13,380
+9,650
+259% +$778K
TFC icon
31
Truist Financial
TFC
$64.7B
$1.04M 0.93%
26,340
+2,100
+9% +$80.5K
FLR icon
32
Fluor
FLR
$7.06B
$1.01M 0.91%
13,200
+1,200
+10% +$91.5K
STT icon
33
State Street
STT
$51.6B
$1.01M 0.91%
15,028
+6,178
+70% +$406K
FBIN icon
34
Fortune Brands Innovations
FBIN
$6.29B
$1.01M 0.9%
29,543
+9,185
+45% +$315K
KMP
35
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$993K 0.89%
12,075
+3,050
+34% +$235K
SBUX icon
36
Starbucks
SBUX
$121B
$967K 0.87%
25,000
+7,700
+45% +$280K
STX icon
37
Seagate
STX
$198B
$957K 0.86%
16,850
+1,050
+7% +$56.6K
MSFT icon
38
Microsoft
MSFT
$3.63T
$956K 0.86%
22,925
+1,950
+9% +$78.9K
AB icon
39
AllianceBernstein
AB
$3.46B
$954K 0.85%
36,880
+5,710
+18% +$143K
KO icon
40
Coca-Cola
KO
$373B
$954K 0.85%
22,525
-11,500
-34% -$467K
GSK icon
41
GSK
GSK
$103B
$948K 0.85%
14,176
– –
DCI icon
42
Donaldson
DCI
$11.3B
$945K 0.85%
22,325
-300
-1% -$12.5K
MDT icon
43
Medtronic
MDT
$109B
$924K 0.83%
14,485
-2,650
-15% -$161K
FUL icon
44
H.B. Fuller
FUL
$3.18B
$914K 0.82%
+19,005
New +$909K
KSU
45
DELISTED
Kansas City Southern
KSU
$911K 0.82%
8,475
-350
-4% -$36.1K
BMO icon
46
Bank of Montreal
BMO
$127B
$898K 0.8%
12,200
-8,650
-41% -$603K
STI
47
DELISTED
SunTrust Banks, Inc.
STI
$874K 0.78%
21,825
+150
+0.7% +$5.84K
INTC icon
48
Intel
INTC
$513B
$858K 0.77%
27,775
-14,000
-34% -$384K
SLB icon
49
SLB Ltd
SLB
$74.6B
$854K 0.76%
7,240
-267
-4% -$27.5K
T icon
50
AT&T
T
$157B
$843K 0.76%
31,558
+6,223
+25% +$167K
1
2
3 4 5

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return

New England Research & Management's Q2 2014 Portfolio in Review

As of Q2 2014, New England Research & Management held 164 positions worth $112M, up 2.3% from $109M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

New England Research & Management's Q2 2014 filing shows 24 new, 48 increased, 65 reduced and 13 closed positions. Its largest new stake was Dorman Products: 16,950 shares worth $836K. The largest sale was Freeport-McMoran, an estimated $1.15M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Energy.

  • New England Research & Management's largest Q2 2014 buy was Dorman Products: 16,950 shares worth $836K.
  • New England Research & Management added most to Procter & Gamble in Q2 2014, an estimated $778K increase.
  • New England Research & Management's biggest Q2 2014 reduction was Baxter International, cutting an estimated $952K.
  • New England Research & Management fully exited Freeport-McMoran in Q2 2014, selling an estimated $1.15M.
  • New England Research & Management's ten largest holdings make up 18% of its $112M portfolio in Q2 2014.
  • New England Research & Management opened 24 new positions and closed 13 in Q2 2014.
  • New England Research & Management's portfolio value rose 2.3% quarter-over-quarter to $112M.

Based on New England Research & Management's 13F filing for Q2 2014, filed 1 Jul 2014.